Trelegy Ellipta is a prescription medication that combines three active ingredients – fluticasone furoate, umeclidinium, and vilanterol – in a single inhaler. This medication is used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, in adults.

Fluticasone furoate is a corticosteroid that helps reduce inflammation in the airways, while umeclidinium is an anticholinergic that helps relax the muscles around the airways to improve breathing. Vilanterol is a long-acting beta agonist that helps open up the airways to make breathing easier.

Trelegy Ellipta is taken once daily and should not be used as a rescue inhaler for sudden breathing problems. It is important to use this medication regularly to get the full benefit of its effects. It may take a few weeks of consistent use before you notice an improvement in your symptoms.

As with any medication, Trelegy Ellipta may cause side effects. Common side effects may include headache, sore throat, cough, and thrush in the mouth or throat. If you experience any severe side effects such as chest pain, rapid heartbeat, or difficulty breathing, seek medical attention immediately.

It is important to discuss your medical history and any other medications you are taking with your healthcare provider before starting Trelegy Ellipta. They can help determine if this medication is right for you and provide guidance on how to use it properly.

Overall, Trelegy Ellipta can be an effective treatment option for managing COPD symptoms and improving quality of life for those living with this chronic condition.